Amyloid Imaging with [11C]PIB PET and MRI in MCI – a pilot study - MCI and PIB
Phase 1
- Conditions
- Patients with Mild Cognitive Impairment (MCI) will be investigated with PIB PET to determin amyloid pathology
- Registration Number
- EUCTR2010-020724-21-AT
- Lead Sponsor
- niversitätsklinik für Neurologie, Medizinische Universität Wien
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Age range between 60-80 years, male and female
Neuropsychological Testing with diagnosis of Mild Cognitive impairment – amnestic or non amnestic type (single and multiple domain).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
major life threatening internal diseases, for example heart failure, cancer, ..
major neurological diseases except MCI, for example major stroke, parkinsonism
major psychiatric diseases except dementia, for example major depression
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method